TrialX NRG-GI008 Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease (Circulate-North America).

Enrolling By Invitation
18 years - 100 years
All
Phase N/A
75 participants needed
1 Location

Brief description of study

Post market clinical follow up of Bycross® device.

Detailed description of study

A prospective, multi-center, non-randomized, observational, post market clinical follow-up study of the ByCross® device to evaluate the safety, technical performance and effectiveness of the ByCross® device and effectiveness of the procedure using the device and adjunctive therapy.

The ByCross® is a single use, disposable, minimal invasive aspiration rotational atherectomy device. The ByCross® is aimed to enable effective revascularization and restore blood flow in peripheral occluded vessels. In cases that the artery is completely blocked such that opening is not possible with currently available solutions and the procedure cannot be completed, the device is capable of crossing the blocked lesion without guiding wire and enables the completion of the procedure in a safe and effective manner, thus potentially eliminating the need for open bypass surgery. The ByCross® can be used in several pathologies: calcified atheroma, old and fresh thrombus and in stent restenosis at peripheral arteries including iliac

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: Peripheral Arterial Disease
  • Age: 18 years - 100 years
  • Gender: All

Inclusion Criteria:

  • Subject has documented symptomatic chronic peripheral vascular disease at a vessel below the aorta bifurcation
  • Candidate for percutaneous intervention
  • Severely stenotic occlusion target vessel (stenosis ≥70%)
  • Subject has been informed on the nature of the study and has provided informed consent
  • Subject is capable of meeting study requirements including presences at follow-up visits

Exclusion Criteria:

  • Patient anatomy excludes use of BYCROSS® device
  • Vessels of the cardiopulmonary, coronary or cerebral circulations
  • Undersized vessel diameters (<3mm)
  • Perforation of the vessel distally or proximally to the occlusion segment prior atherectomy
  • Subintimal position of the guiding catheter or the guidewire
  • Use in stents or stent grafts if the guidewire has become threaded at any point in the wire mesh of stent or stent graft or the lining of the stent graft
  • Target is at vessel segment which includes tortuous course with radius of curvature <= 40mm
  • Access pathway includes tortuous course with radius of curvature <= 25mm, in specific extremely sharp aortic bifurcation
  • In aneurysmatically altered iliac vessel segments
  • If the introducer sheath, the guide catheter, the guidewire or the BYCROSS® sustains any visible damage, especially kinking
  • In the fracture areas of broken stents
  • Known or suspected allergy to any of the components of the system or to a medicinal product to be administered in connection with the planned procedure
  • Persistent vasospasm
  • During use of a defibrillator on the patient

Updated on 21 Oct 2022. Study ID: 895752
If you need assistance finding a non-cancer clinical research study or if you have any questions, please email psom-ocr@pobox.upenn.edu For Cancer trials contact Penn Medicine's Cancer Trial Navigator at: PMCancerResearch@pennmedicine.upenn.edu or 215-349-8245

Study is selecting its participants from a population, or group of people, decided on by the researchers in advance.

Contact Abramson Cancer Center Navigator